News
Press Releases
Mercy BioAnalytics Adds Marketing and Portfolio Management Leadership to Support Diagnostic Test Development and Commercialization
NATICK, MA – September 11, 2023 – Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced that it has added two senior executives to the Company’s leadership team as it continues development...
Mercy BioAnalytics Appoints Diagnostics Industry Trailblazer Dr. Myla Lai-Goldman to Its Board of Directors
NATICK, MA – April 24, 2023 – (Business Wire) Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced the appointment of Myla Lai-Goldman, MD, to its Board of Directors. “Myla’s visionary...
Mercy BioAnalytics Raises $41 Million in Series A Financing to Advance Novel Mercy Halo Liquid Biopsy Platform for Early Cancer Detection
NATICK, MA – April 03, 2023 – (Business Wire) Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced it has closed a $41 million Series A financing round. The oversubscribed financing was...
Mercy BioAnalytics Adds Scientific, Quality, and Regulatory Leadership in Preparation for Clinical Development
NATICK, MA – March 23, 2023 – (Business Wire) Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced that it has added two senior executives as the Company transitions from research to...
Mercy BioAnalytics Announces Executive Leadership Changes
NATICK, MA – February 15, 2023 – (Business Wire) Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced that Dawn Mattoon, PhD, has assumed the role of Chief Executive Officer and a...
Mercy BioAnalytics Appoints Dawn Mattoon, PhD, as Chief Operating Officer
NATICK, MA – July 11, 2022 – Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced the appointment of experienced biotechnology executive, Dawn Mattoon, PhD, as Chief Operating Officer,...
Novel Assay for Early Detection of Ovarian Cancer from Mercy BioAnalytics Significantly Outperforms CA125 in New Research Presented at ASCO Annual Meeting
Mercy Halo Data Demonstrates Promise of Novel Extracellular Vesicle Biomarker-Based Approach for Early Cancer Detection Natick, MA – May 27, 2022 - Mercy BioAnalytics™, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer,...
Events
National Lung Cancer Round Table Annual Meeting
MERCY ATTENDING!
Washington, DC
December 4-5, 2023
Meet with Us
We’d love to meet with you at our next show. If you will be attending one of the above events, let’s connect. Simply fill out the form below and we will be in touch. Great things can happen when great minds get together!